Parag Milk Foods Q1 FY19 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- The company targets revenues of Rs. 2700 to 3000 Crores over the next two years (Page 11).
- Distribution expansion is a key driver, currently at 2.6-2.7 lakh retail outlets with a plan to add 9,000 to 10,000 outlets per month, roughly 1-1.2 lakh new outlets annually (Pages 16, 21).
- Value-added products like cheese, ghee, fresh products, health & nutrition, beverages, and UHT milk are expected to drive growth (Pages 9, 15, 19).
- Early market acceptance of new products (e.g., 5 lbs profile priced ~10% lower than ON) is positive, with repeated demand leading to portfolio expansion and regional reach increase (Page 22).
- Export incentives (10% duty-free subsidy) may increase exports, currently at ~3-4% of topline, with potential significant growth (Pages 20, 21).
- Milk procurement is projected to grow ~10% annually by leveraging existing farmers and expanding geographically (Page 19).
- Operating margin guidance is 11-12% by FY20, reflecting growth and efficiency (Page 19).
See what Parag Milk Foods management said on margin guidance — free account, 30 seconds.
Fundraise plans
- No aggressive capital expenditure plans are currently planned except for the Sonipat plant as mentioned on Page 18.
- The company is focused on expanding its distribution network and product launches rather than large new investments.
- Existing debt stands at around Rs. 264 Crores (Page 16), with stable levels quarter-on-quarter.
- Cost of borrowing averages around 9.5%-10% including both working capital and term loans (Page 16).
- There is no explicit mention of any immediate or upcoming fundraising via debt or equity in the provided transcript.
- Management appears focused on organic growth funded by existing resources and operational cash flows.
- Future capex beyond Sonipat plant may be evaluated based on performance in coming quarters (Page 18).
See what Parag Milk Foods management said on order book — free account, 30 seconds.
Capex plans
Yes- Capex related to Sonipat plant acquisition from Danone is completed; around 60% of the planned Rs. 30 Crores invested so far (Page 7).
- Further investments in Delhi NCR are planned, with more spending to follow as research is completed in that geography (Page 7).
- No aggressive capex mode planned outside the Sonipat plant for the next six quarters (Page 18).
- Distribution expansion is a key strategic initiative, targeting addition of 9,000 to 10,000 retail outlets per month, adding around 1-1.2 lakh outlets in the fiscal year (Pages 16, 21).
- A pilot project focused on distribution optimization (TOC model) has started in a metro area, showing positive growth; plans to scale up to other cities (Page 13).
- Focus continues on building health and nutrition segment with new product launches (e.g., Avvatar) and expanding product portfolio (Pages 12, 13).
Track Parag Milk Foods — get its next earnings analysis in your feed
How does Parag Milk Foods rank vs peers in Food Products?
Pro featureHow does Parag Milk Foods rank in Food Products?
Compare Parag Milk Foods against every Food Products company (Q1 FY19) on revenue, margins and earnings-call signals.
Continue your research
What Parag Milk Foods's management said in earlier quarters
Others in Food Products this season
- Sheetal Cool Products Ltd (Q1 FY27)
Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro
- Mukka Proteins Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Mukka Proteins Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Shri Ahimsa Naturals Ltd (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.